Clinical significance of consecutive shocks in patients with left ventricular dysfunction treated with implantable cardioverter defibrillators

被引:7
|
作者
Endoh, Y [1 ]
Ohnishi, S [1 ]
Kasanuki, H [1 ]
机构
[1] Tokyo Womens Med Univ, Heart Inst Japan, Tokyo, Japan
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1999年 / 22卷 / 01期
关键词
implantable cardioverter defibrillator; consecutive shocks; mortality;
D O I
10.1111/j.1540-8159.1999.tb00330.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of the present study was to determine the clinical significance of consecutive automatic shocks delivered by implantable cardioverter defibrillators (ICDs). Sixty-four patients who received ICDs at our institution between January 1990 and July 1997 were included in this study. There were 53 men and 11 women with a mean age of 50 +/- 14 years. During a follow-up period ranging between 0.2 and 73 months (mean 23 +/- 21 months), 17 patients received consecutive shocks (group A), 29 patients received single shocks (group B), and 18 patients received no ICD therapy (group C). Clinical characteristics, episodes of ICD therapy, and prognosis were compared among the three groups. There were no significant differences among the three groups with regard 50 clinical characteristics, time to first ICD therapy number of antitachycardia pacing episodes, or frequency of inappropriate discharges. The mortality rate tvas higher in group A than in groups B and C (P = 0.0021). The sensitivity of consecutive shocks in predicting death was 70%, the specificity was 88%, and the predictive accuracy was 81% in patients with left ventricular ejection fractions < 35%. In summary consecutive shocks are a clinically important event in patients with ICDs. Specifically, patients who receive consecutive shocks and have a depressed left ventricular function should be considered particularly high risk.
引用
收藏
页码:187 / 191
页数:5
相关论文
共 50 条
  • [31] Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators
    Brigadeau, F
    Kouakam, C
    Klug, D
    Marquié, C
    Duhamel, A
    Mizon-Gérard, F
    Lacroix, D
    Kacet, S
    EUROPEAN HEART JOURNAL, 2006, 27 (06) : 700 - 707
  • [32] Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients
    Rorris, Filippos-Paschalis
    Charitos, Christos
    HEART FAILURE REVIEWS, 2021, 26 (04) : 763 - 765
  • [33] Implantable Cardioverter-Defibrillators Are Not Associated with Survival in Patients with a Left Ventricular Assist Device
    Sayer, Gabriel T.
    Bhat, Geetha
    Gallagher, Colleen
    Macaluso, Gregory
    Cotts, William
    Tatooles, Antone
    Spear, William
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S58 - S58
  • [34] Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004
    Al-Khatib, SM
    Sanders, GD
    Mark, DB
    Lee, KL
    Bardy, GH
    Bigger, JT
    Buxton, AE
    Connolly, S
    Kadish, A
    Moss, A
    Feldman, AM
    Ellenbogen, KA
    Singh, S
    Califf, RM
    AMERICAN HEART JOURNAL, 2005, 149 (06) : 1020 - 1034
  • [35] Impact of left ventricular mass and diameter on defibrillation thresholds in patients with implantable cardioverter defibrillators
    Lakkireddy, DR
    Burkhardt, DJ
    Ryschon, K
    Patel, D
    Bhateja, R
    Prasad, S
    Thal, S
    Kondur, A
    Wazni, O
    Kanj, M
    Civello, K
    Schweikert, R
    Saliba, W
    Bhargava, M
    Arruda, M
    Chung, M
    Wilkoff, B
    Tchou, P
    Natale, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 15A - 15A
  • [36] Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators
    Gillis, AM
    Sheldon, RS
    Wyse, G
    Duff, HJ
    Cassidy, MR
    Mitchell, LB
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (05) : 492 - 498
  • [37] Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients
    Filippos-Paschalis Rorris
    Christos Charitos
    Heart Failure Reviews, 2021, 26 : 763 - 765
  • [38] Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices
    Lee, William
    Tay, Andre
    Subbiah, Rajesh N.
    Walker, Bruce D.
    Kuchar, Dennis L.
    Muthiah, Kavitha
    Macdonald, Peter S.
    Keogh, Anne M.
    Kotlyar, Eugene
    Jabbour, Andrew
    Spratt, Philip
    Jansz, Paul C.
    Granger, Emily
    Dhital, Kumud
    Hayward, Christopher S.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (08): : 925 - 933
  • [39] Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction
    Ermis, C
    Lurie, KG
    Zhu, AX
    Collins, J
    Vanheel, L
    Sakaguchi, S
    Lu, F
    Pham, S
    Benditt, DG
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (08) : 862 - 866
  • [40] Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function? Discussion
    Touboul
    Block
    Wever
    Kuck
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 : 68 - 68